A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation

Stopped early

Conditions studied: Atrial Fibrillation

In brief

The purpose of this study is to evaluate the impact of a hospital quality improvement (QI) program on the use of guideline-recommended oral anticoagulants (OAC) in hospitalized patients with atrial fibrillation (AF) at risk for ischemic stroke. Specifically, the study will determine whether the intervention, compared to Usual Care, will result in a greater increase in the proportion of patients with AF at risk for ischemic stroke who are appropriately treated with OAC.

Key facts

Study ID
NCT03382613
Run by
Janssen Scientific Affairs, LLC
People needed
2000
Starts
2017-12-29
Expected to finish
2019-12-03
Last updated by the study team
2019-12-26

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.